Free Trial

Marchex (NASDAQ:MCHX) Given Sell (D-) Rating at Weiss Ratings

Marchex logo with Computer and Technology background

Key Points

  • Marchex's stock has received a "sell (D-)" rating from Weiss Ratings, while Zacks Research upgraded it to a "strong-buy," indicating mixed analyst opinions on the stock.
  • The company's stock price is currently around $1.98, with a market cap of $87.47 million and a significant volatility reflected in its beta of 1.99.
  • Institutional investors own 73.46% of Marchex's stock, with notable recent acquisitions by firms including Millennium Management and Edenbrook Capital.
  • MarketBeat previews the top five stocks to own by November 1st.

Marchex (NASDAQ:MCHX - Get Free Report)'s stock had its "sell (d-)" rating reiterated by investment analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

Separately, Zacks Research raised shares of Marchex from a "hold" rating to a "strong-buy" rating in a report on Monday. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy".

Get Our Latest Stock Report on MCHX

Marchex Trading Up 8.2%

Shares of Marchex stock opened at $1.98 on Wednesday. Marchex has a 12-month low of $1.26 and a 12-month high of $2.40. The company has a market cap of $87.47 million, a price-to-earnings ratio of -18.00 and a beta of 1.99. The company's 50-day moving average price is $1.94 and its 200-day moving average price is $1.81.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of MCHX. Millennium Management LLC grew its position in Marchex by 55.5% during the fourth quarter. Millennium Management LLC now owns 21,287 shares of the technology company's stock valued at $37,000 after acquiring an additional 7,598 shares during the last quarter. Kanen Wealth Management LLC bought a new position in shares of Marchex in the first quarter worth approximately $813,000. Edenbrook Capital LLC grew its holdings in shares of Marchex by 0.7% in the first quarter. Edenbrook Capital LLC now owns 14,664,380 shares of the technology company's stock worth $23,903,000 after purchasing an additional 102,475 shares during the last quarter. Jane Street Group LLC purchased a new stake in Marchex in the first quarter worth $30,000. Finally, Acuitas Investments LLC purchased a new stake in Marchex in the second quarter worth $141,000. 73.46% of the stock is currently owned by institutional investors.

Marchex Company Profile

(Get Free Report)

Marchex, Inc, a conversation intelligence company, provides conversational analytics and related solutions in the United States, Canada, and internationally. Its products include Marketing Edge that identifies which campaigns and channels are driving inbound conversations, evaluates what happens during those conversations, and closes the sales loop by connecting converted sales to marketing driven leads; Sonar Business Text Messaging, an artificial intelligence (AI) empowered intelligent workflow enabled mobile messaging solution that enables operations, sales, and marketing teams to communicate personally with field staff, prospects, and customers; Marchex Platform Services, a robust API-based conversation intelligence product that allows executives, sales, customer engagement, and marketing teams to apply Marchex AI to most any calls, regardless of communication platform, in order to identify actionable insights from conversations with their customers; Spotlight, an AI conversation analytics product for multi-location businesses; and Engage, a solution that provides locations with applications to enhance their overall performance.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marchex Right Now?

Before you consider Marchex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.

While Marchex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.